NIH Exploratory/Developmental Research Grant

The NIH Exploratory/Developmental Research Grant (R21) is the exploratory counterpart to the R01, built for novel ideas, high-risk directions, and early studies that do not yet have R01-level preliminary data. Two parent NOFOs are active, with clinical-trial required and not-allowed variants open through January 8, 2028. It is a grant mechanism with three cycles per year and standard new-application due dates in February, June, and October. The parent record is open to U.S.-based for-profit, nonprofit, university, and research-organization applicants, and it excludes individuals. The parent announcement treats it as a sibling of the R01 umbrella, but the R21 is the shorter, lower-budget option for projects that are still proving the concept. The R21 is usually the better fit when a team needs a shorter runway and a lower budget ceiling than an R01. It works best for a focused exploratory question, a new method, or a pilot study that can justify a later transition to a larger project.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.